Boston, MA, July 25, 2003- Exergen's Temporal Artery Thermometers, having received world-wide acclaim for fast, accurate, and truly non-invasive temperature, have attracted extensive attention from many who may be unaware of the extent of Exergen's patent portfolio directed to forehead thermometers. Exergen owns 11 United States patents protecting its TAT-2000C consumer model (Nos. 6,292,685; 4,636,091; 5,012,813; 5,199,436; 5,653,238; 5,874,736; 6,045,257; 6,047,205; 6,056,435; 6,299,347; 6,319,206) and an additional 8 US Patents protecting its professional models. Exergen also owns international counterparts to the US patents and additional US and foreign patents are pending. The patents covering the products are printed on every Exergen thermometer.
Exergen concluded a patent infringement suit in 2001 against Safety 1st, Inc. for a forehead thermometer with an amicable settlement when Safety 1st agreed to stop activities with the thermometer, which was manufactured by SAAT, Ltd. of Israel (link to release). In an ongoing suit in US District Court in Boston against SAAT, Daiwa Products, Inc. of Florida, Hana Microelectronics of China, and others, for the same product offered by Safety 1st, Exergen is vigorously defending its patent rights in asserting five patents against the SAAT product.
Exergen Corporation is world leader in the science and technology of non-invasive
thermometry systems. Developed by teams led by Dr. Francesco Pompei, President,
Exergen's products are well-known for their innovation, accuracy, and reliability.
Trained at MIT (BS and MS degrees) and Harvard University (SM and Ph.D.), Dr.
Pompei holds nearly 60 US patents and numerous international counterparts in
the fields of non-invasive thermometry and thermal management of people and
machinery. In addition to his Exergen position, Dr. Pompei holds an appointment
to the Department of Physics at Harvard.
Contact:
Marybeth Pompei
Vice President and Chief Clinical Scientist
617-923-9900, ext.202
mpompei@exergen.com